MedPath

Naval Medical Center San Diego (NMCSD) - Ambulatory Continuous Peripheral Nerve Blocks for Treatment of Post-Amputation Phantom Limb and Stump Pain

Not Applicable
Terminated
Conditions
Stump Pain
Amputation
Phantom Limb
Interventions
Drug: normal saline (placebo)
Registration Number
NCT00768248
Lead Sponsor
University of California, San Diego
Brief Summary

The purpose of this research study is to determine if putting local anesthetic-or numbing medication-through one or two tiny tube(s) placed next to the nerves that go to an amputated limb will decrease phantom limb and/or stump pain.

Detailed Description

Specific Aim 1: To determine if, compared with current standard-of-care treatment, the addition of an ambulatory continuous peripheral nerve block decreases post-amputation phantom limb and stump pain.

Hypothesis 1: Following upper or lower extremity amputation, phantom limb and/or stump pain will be significantly decreased four weeks following a multiple-day ambulatory continuous peripheral nerve block as compared with patients receiving standard-of-care treatment (as measured on the 11-point numeric rating scale).

Specific Aim 2: To investigate the possible relationship between the addition of a multiple-day ambulatory continuous peripheral nerve block to standard-of-care treatment of post-amputation phantom limb and/or stump pain and cortical reorganization.

Hypothesis 2: Following upper or lower extremity amputation with subsequent phantom limb pain/sensation and/or stump pain, the addition of a multiple-day ambulatory continuous peripheral nerve block to standard-of-care treatment will result in cortical reorganization during and four-weeks following the perineural infusion (as measured by MRI).

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
2
Inclusion Criteria
  • previous upper or lower limb amputation including at least one metacarpal or metatarsal bone, respectively
  • age 18 years or older
  • phantom limb and/or stump pain described as at least a 2 on the NRS for the previous week [and pain occurring on a weekly basis over the previous month]
  • willing to have an ambulatory perineural infusion for 6 days
  • willing to avoid additional "new" analgesic interventions from 4 weeks prior to at least 4 weeks following catheter placement, and preferably to 6 months following catheter placement
  • the availability of a "caretaker" who will transport the subject home following the procedure and remain with the subject for the first night of the infusion
Exclusion Criteria
  • known hepatic or renal insufficiency
  • allergy to the study medications
  • possessing a contraindication to perineural catheter placement or perineural local anesthetic infusion

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Placebonormal saline (placebo)3-7 days of perineural normal saline infusion
Activeperineural ropivacaine3-7 days of perineural local anesthetic infusion
Primary Outcome Measures
NameTimeMethod
Primary Analysis Will Compare the Two Treatment Groups for the Phantom Limb/Stump Pain Change From Baseline to 4 Weeks Following the Initial Catheter PlacementWeek 4
Secondary Outcome Measures
NameTimeMethod
Emotional Functioning · Beck Depression Inventorypre-intervention; and then day 28 and 365 post-intervention
Nervous System Reorganization [if Patient Elected to Participate in the MRI Procedures] · MRI Procedurepre-intervention; and then 8 and 28 days post-intervention
Pain · 11-point Numeric Rating Scale of Pain Intensity · Usage of Baseline and Rescue Analgesics in Previous 24 Hours · Patient Global Impression of Change ScaleDay 8, Day 28, Month 12
Physical Functioning · Brief Pain Inventorypre-intervention, then days 1, 3, 8, 28, 84, and 365

Trial Locations

Locations (1)

Naval Medical Center San Diego

🇺🇸

San Diego, California, United States

© Copyright 2025. All Rights Reserved by MedPath